The global market for Intravenous Equipment is estimated at US$11.2 Billion in 2023 and is projected to reach US$14.2 Billion by 2030, growing at a CAGR of 3.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Despite promising market potential, challenges such as a shortage of trained healthcare professionals and high equipment development costs remain. In rural areas, limited access to trained professionals exacerbates this shortage. High R&D and production costs also lead to increased prices, restricting access for some patients and straining healthcare budgets. Close collaboration between medical device companies, healthcare providers, and insurers is essential to create innovative and affordable equipment. Overall, the infusion therapy market has a bright future, with significant potential to enhance patient outcomes and quality of life through continuous advancements.
Despite promising market potential, challenges such as a shortage of trained healthcare professionals and high equipment development costs remain. In rural areas, limited access to trained professionals exacerbates this shortage. High R&D and production costs also lead to increased prices, restricting access for some patients and straining healthcare budgets. Close collaboration between medical device companies, healthcare providers, and insurers is essential to create innovative and affordable equipment. Overall, the infusion therapy market has a bright future, with significant potential to enhance patient outcomes and quality of life through continuous advancements.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the IV Catheters segment, which is expected to reach US$4.8 Billion by 2030 with a CAGR of a 4.0%. The Securement Devices segment is also set to grow at 4.3% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $3.0 Billion in 2023, and China, forecasted to grow at an impressive 6.2% CAGR to reach $2.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Intravenous Equipment Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Intravenous Equipment Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Intravenous Equipment Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as AngioDynamics Inc., Arcomed AG, ASCOR S.A., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 91 Featured):
- AngioDynamics Inc.
- Arcomed AG
- ASCOR S.A.
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd.
- Fresenius SE & Co. KGaA
- Halyard Health Inc.
- ICU Medical Inc.
- Insulet Corp.
- Medtronic PLC
- Moog Inc.
- Nipro Corporation
- Smiths Medical
- Tandem Diabetes Care Inc.
- Teleflex Inc.
- Terumo Corp.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AngioDynamics Inc.
- Arcomed AG
- ASCOR S.A.
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd.
- Fresenius SE & Co. KGaA
- Halyard Health Inc.
- ICU Medical Inc.
- Insulet Corp.
- Medtronic PLC
- Moog Inc.
- Nipro Corporation
- Smiths Medical
- Tandem Diabetes Care Inc.
- Teleflex Inc.
- Terumo Corp.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 218 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 11.2 Billion |
| Forecasted Market Value ( USD | $ 14.2 Billion |
| Compound Annual Growth Rate | 3.5% |
| Regions Covered | Global |
